中国实用外科杂志
• 专题笔谈 • 上一篇 下一篇
肖永胜,周 俭
出版日期:
发布日期:
Online:
Published:
摘要:
肝癌术后复发与转移是进一步提高肝癌疗效的瓶颈,在缺乏公认的预防复发转移手段的前提下,复发性肝癌的早诊早治显得尤为重要。应综合考虑肿瘤的生物学特征、肝脏储备功能、残余肝体积以及病人的全身情况等因素,选择再切除、挽救性肝移植、局部消融、经肝动脉栓塞化疗、放疗和系统治疗等方法,对复发性肝癌进行多学科综合治疗。在缺少前瞻性随机对照临床研究结果的情况下,Meta分析是评价不同治疗策略疗效的重要依据。
关键词: 肝细胞癌, 复发转移, 再治疗
Abstract:
Reasonable option of re-treatment approaches for recurrent hepatocellular carcinoma XIAO Yong-sheng,ZHOU Jian. Liver Cancer Institute and Zhongshan Hospital,Fudan University,Shanghai 200032,China Corresponding author:ZHOU Jian,E-mail:zhou.jian@ zs-hospital.sh.cn Abstract Recurrence and metastasis of liver cancer are the main obstacle influencing long-term survival of patients accepted curative therapy. Early detection,diagnosis and treatment of recurrent tumor should be performed for the improvement of surgical effects. According to the tumor stage,liver function,remnant liver volume and patient’s performance,multidisciplinary management approach is available for recurrent tumor including curative re-resection,salvage liver transplantation,radiofrequency ablation,trans-arterial chemoembolization,radiation therapy and systemic therapy. The meta-analysis results are the prior basis to evaluate different therapeutic strategy effect in the absence of prospective randomized controlled clinical study’s evidence.
Key words: hepatocellular carcinoma, recurrence and metastasis, re-treatment
肖永胜,周 俭. 肝癌术后复发再治疗方式合理选择[J]. 中国实用外科杂志, DOI: 10.7504/CJPS.ISSN1005-2208.2016.06.11.
0 / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: https://www.zgsyz.com/zgsywk/CN/10.7504/CJPS.ISSN1005-2208.2016.06.11
https://www.zgsyz.com/zgsywk/CN/Y2016/V36/I06/627